These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17353777)

  • 41. A pilot study of prophylactic donor lymphocyte infusions to prevent relapse in adult acute lymphoblastic leukemias after allogeneic hematopoietic stem cell transplantation.
    Lutz C; Massenkeil G; Nagy M; Neuburger S; Tamm I; Rosen O; Dörken B; Arnold R
    Bone Marrow Transplant; 2008 May; 41(9):805-12. PubMed ID: 18195682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term use of oral beclomethasone dipropionate for the treatment of gastrointestinal graft-versus-host disease.
    Iyer RV; Hahn T; Roy HN; Battiwalla M; Cooper M; Anderson B; Paplham P; Brown K; Bambach B; Segal BH; McCarthy PL
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):587-92. PubMed ID: 16041308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful treatment of steroid-refractory hepatitic variant of liver graft-vs-host disease with pulse cyclophosphamide.
    Mayer J; Krejci M; Pospisil Z; Doubek M; Janikova A; Zackova D; Racil Z; Smardova L; Navratil M; Kamelander J
    Exp Hematol; 2009 Jun; 37(6):767-73. PubMed ID: 19463776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host disease.
    Elad S; Or R; Resnick I; Shapira MY
    Transpl Int; 2003 Sep; 16(9):665-70. PubMed ID: 12768230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
    Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease.
    Calzavara Pinton P; Porta F; Izzi T; Venturini M; Capezzera R; Zane C; Notarangelo LD
    Haematologica; 2003 Oct; 88(10):1169-75. PubMed ID: 14555314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease.
    Rossetti F; Dall'Amico R; Crovetti G; Messina C; Montini G; Dini G; Locatelli F; Argiolu F; Miniero R; Zacchello G
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():175-81. PubMed ID: 8932825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effect.
    Huang XJ; Wang Y; Liu DH; Xu LP; Liu KY; Chen H; Chen YH; Han W; Shi HX
    Bone Marrow Transplant; 2009 Sep; 44(5):309-16. PubMed ID: 19234512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunotherapy by allogeneic stem cell transplantation.
    Ringdén O
    Adv Cancer Res; 2007; 97():25-60. PubMed ID: 17419940
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A double-blind placebo-controlled trial of a leukotriene receptor antagonist in chronic pancreatitis in humans.
    Cartmell MT; O'Reilly DA; Porter C; Kingsnorth AN
    J Hepatobiliary Pancreat Surg; 2004; 11(4):255-9. PubMed ID: 15368110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis.
    Yamada MF; Miyamura K; Fujiwara T; Kohata K; Okitsu Y; Ohguchi H; Yamamoto J; Yokoyama H; Tomiya Y; Ishizawa K; Kameoka J; Harigae H
    Transplant Proc; 2008 Dec; 40(10):3637-42. PubMed ID: 19100456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic graft-versus-host disease: where do we go from here?
    Farag SS
    Bone Marrow Transplant; 2004 Mar; 33(6):569-77. PubMed ID: 14743199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA).
    Vogelsang GB; Wolff D; Altomonte V; Farmer E; Morison WL; Corio R; Horn T
    Bone Marrow Transplant; 1996 Jun; 17(6):1061-7. PubMed ID: 8807115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality of life associated with acute and chronic graft-versus-host disease.
    Lee SJ; Kim HT; Ho VT; Cutler C; Alyea EP; Soiffer RJ; Antin JH
    Bone Marrow Transplant; 2006 Aug; 38(4):305-10. PubMed ID: 16819438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD.
    Andree H; Hilgendorf I; Leithaeuser M; Junghanss C; Holzhueter S; Loddenkemper C; Steiner B; Freund M; Wolff D
    Bone Marrow Transplant; 2008 Oct; 42(8):541-6. PubMed ID: 18641680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.
    Schultz KR; Miklos DB; Fowler D; Cooke K; Shizuru J; Zorn E; Holler E; Ferrara J; Shulman H; Lee SJ; Martin P; Filipovich AH; Flowers ME; Weisdorf D; Couriel D; Lachenbruch PA; Mittleman B; Vogelsang GB; Pavletic SZ
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):126-37. PubMed ID: 16443511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical utility of rituximab in chronic graft-versus-host disease.
    Bates JS; Engemann AM; Hammond JM
    Ann Pharmacother; 2009 Feb; 43(2):316-21. PubMed ID: 19193571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants.
    Hoyt R; Ritchie DS; Roberts AW; Macgregor L; Curtis DJ; Szer J; Grigg AP
    Bone Marrow Transplant; 2008 Apr; 41(7):651-8. PubMed ID: 18176619
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.
    Couriel D; Carpenter PA; Cutler C; Bolaños-Meade J; Treister NS; Gea-Banacloche J; Shaughnessy P; Hymes S; Kim S; Wayne AS; Chien JW; Neumann J; Mitchell S; Syrjala K; Moravec CK; Abramovitz L; Liebermann J; Berger A; Gerber L; Schubert M; Filipovich AH; Weisdorf D; Schubert MM; Shulman H; Schultz K; Mittelman B; Pavletic S; Vogelsang GB; Martin PJ; Lee SJ; Flowers ME
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):375-96. PubMed ID: 16545722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pilot study of oral montelukast added to standard therapy for acute asthma exacerbations in children aged 6 to 14 years.
    Nelson KA; Smith SR; Trinkaus K; Jaffe DM
    Pediatr Emerg Care; 2008 Jan; 24(1):21-7. PubMed ID: 18165796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.